Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Synbiotics logo — Pioneering a new era in oncolytic virus therapies with enhan...

Synbiotics

Pioneering a new era in oncolytic virus therapies with enhanced targeting, improved safety, and superior tumor-killing capabilities.

Biotechnology, Health Care +2

General Information

Company Name Synbiotics
Industries Biotechnology, Health Care, Health and Wellness +1
Social

Get notified when Synbiotics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Synbiotics

Synbiotics is pioneering a new era in oncolytic virus therapies with enhanced targeting, improved safety, and superior tumor-killing capabilities. Specializing in the research and development of oncolytic virus drugs, the company utilizes synthetic biology technology and an adenovirus platform to create highly targeted, safer, and more effective tumor-killing solutions for various cancer indications. This new generation of oncolytic virus products boasts enhanced capabilities. Founded by Professor Xie Zhen's team from the Department of Automation at Tsinghua University, Synbiotics operates in the Biotechnology, Health Care, and Pharmaceutical industries. As of now, specific information about the company's funding, investors, founding date, and headquarters location is not available. However, Synbiotics' innovative approach to oncolytic virus therapies and its use of advanced technology make it a noteworthy candidate for potential venture capital investment.

Taxonomy: oncolytic virus, drug research, synthetic biology technology, adenovirus platform, cancer therapy, tumor-killing capabilities, biomedical innovation, synbiotics, Tsinghua University, Professor Xie Zhen, targeted therapy, tumor indications, biomedical research, cancer treatment, innovative therapies

No funding data available for Synbiotics yet.

Get notified when Synbiotics raises funding

Synbiotics Alternatives & Competitors

Synbiotics vs
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics United States

KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer trea...

Series A
43 employees
Health Care, Health and Wellness
Synbiotics vs
IconOVir Bio
IconOVir Bio United States

Pushing the envelope: Our mission is to cure cancer and restore life to every patient everywhere

Series A
7 employees
Biotechnology, Life Sciences
Synbiotics vs
Seneca Therapeutics, Inc.
Seneca Therapeutics, Inc. United States

Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for patients...

Series B
10 employees
Biopharma, Biotechnology

FAQ About Synbiotics

Pioneering a new era in oncolytic virus therapies with enhanced targeting, improved safety, and superior tumor-killing capabilities.
Synbiotics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Top alternatives and competitors to Synbiotics include KaliVir Immunotherapeutics, IconOVir Bio, Seneca Therapeutics, Inc., OncoMyx Therapeutics, VYROBIO. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Synbiotics and KaliVir Immunotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Synbiotics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy